← Back to Clinical Trials
Recruiting NCT06198023

NCT06198023 Targeting Social Function in Anxiety and Eating Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06198023
Status Recruiting
Phase
Sponsor University of Texas Southwestern Medical Center
Condition Eating Disorders
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-02-28
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
EducationalInteractive

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-02-28 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions -- one educational, one interactive -- for their effectiveness in improving clinical outcomes in patients with eating disorders. Patients in both interventions will receive education about social function in eating disorders, but those in the interactive treatment group will complete an additional collaborative art task. Participants will: * attend a baseline study visit to complete clinical interviews, cognitive testing, and behavioral tasks * complete a pre-intervention assessment with questionnaires * attend eight sessions of their assigned treatment group over the course of 12 weeks * complete three virtual follow-up assessments 4, 8, and 12 months from their baseline * attend a final study visit to repeat some clinical interviews, cognitive testing, and behavioral tasks Researchers will compare changes in eating disorder, mood, and anxiety symptoms as well as test results from baseline and final study visits for each group to see if * patients can be treated effectively with education alone or if an interactive group component produces additional benefits * cognitive and behavioral task performance are associated with recovery or illness state.

Eligibility Criteria

Inclusion Criteria: * In the past 12 months, has met DSM-5 criteria met for an eating disorder (Anorexia Nervosa, Atypical Anorexia Nervosa, Bulimia Nervosa, Avoidant-Restrictive Food Intake Disorder, or Other Specified Feeding or Eating Disorder) and/or an anxiety disorder (Generalized Anxiety Disorder, Social Anxiety Disorder) * Between the ages of 18-30 Exclusion Criteria: * Current inpatient or residential treatment * Medical instability or safety/suicide risk as determined by the PI

Contact & Investigator

Central Contact

Ava Ryan

✉ edresearch@utsouthwestern.edu

📞 214-648-4617

Principal Investigator

Carrie J McAdams, MD PhD

PRINCIPAL INVESTIGATOR

University of Texas Southwestern Medical Center

Frequently Asked Questions

Who can join the NCT06198023 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06198023 currently recruiting?

Yes, NCT06198023 is actively recruiting participants. Contact the research team at edresearch@utsouthwestern.edu for enrollment information.

Where is the NCT06198023 trial being conducted?

This trial is being conducted at Dallas, United States.

Who is sponsoring the NCT06198023 clinical trial?

NCT06198023 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Carrie J McAdams, MD PhD at University of Texas Southwestern Medical Center. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology